Plain-English translation of NCT06698679 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →Researchers are studying chemicals naturally found in blood plasma to understand breast cancer better. By comparing blood samples from healthy women, women newly diagnosed with breast cancer, and women who have finished treatment, the study aims to identify markers that could predict breast cancer risk and help doctors personalize treatment plans.
Cancer cells change how the body processes chemicals and energy, leaving traces in the blood. This study exists to find these chemical fingerprints so doctors can better predict who might develop breast cancer and which treatments will work best for each patient.
You likely qualify if…
You likely don't qualify if…
Depending on which group you join, you may donate a blood sample once, provide samples before and during treatment, or provide samples after you have finished treatment. The study collects your blood alongside information about your diagnosis and how your treatment works. Most visits involve a simple blood draw; the study does not involve taking experimental medications.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
China
Enrollment target
~1,000 participants
Started
November 2024
Primary completion
June 2031
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in November 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Liu Hua, Ph. D
Shengjing Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.